GREY:IMVIF - Post by User
Post by
antisenseon Jun 19, 2018 11:23am
234 Views
Post# 28191778
IMV thoughts and Exon Skipping
IMV thoughts and Exon Skipping Here is a little morale boost for all of us as we watch iMV tank. I am disspointed with ill conceived NASDAQ plan and 3.2 conversion without follow up "POP" to their technology. The Incyte results were meek at best and i think investors (and clinicians) wanted to see more of a reponse in tumour REGRESSION in the trial patients.
Like i had said before the Incyte trial is really a dud and I'm looking forward to the results with Merck on Keytruda.
Some inspiration from a biotech called Sarepta. see link below for something incredible. For all the science nerds out there i never even heard of Exon Skipping before. It's simply unbelieable what these companies can do now. This kinda puts IMV's tech to shame tbh.
sarepta.com/pipeline/exon-skipping-duchenne Hopefully we get some really positive
NEW results soon and we too could see a 55%+ spike in a day!!
GLTA